Coya Therapeutics Inc.

COYA | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.95

+$0.06 (+1.23%)

At close: Sep 21, 2026, 4:00 PM ET

$4.95

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.23%

(1D)

Rating

Updated: Aug 29, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $116.11M

1D Range

4.83 5.04

52W Range

3.71 7.75

Valuation (TTM)

PE -4.63

PB 0.00

EV/EBITDA 1,951.25

Valuation (NTM)

Forward PE N/A

Forward PEG -0.57

Price Target $12

Cash Flow

FCF Yield -11783.1%

SBC Adj. FCF Yield -14488.8%

SBC Impact -23.0%

Margins

Gross Margin 99.9%

Operating Margin -282.3%

FCF Margin -170613.5%

Growth (CAGR)

Revenue 3Y | 5Y -12.8% | 45.7%

Dil EPS 3Y | 5Y -15.2% | 3.3%

FCF 3Y | 5Y -149.7% | -99.7%

Returns

ROA -0.1%

ROE -0.2%

ROIC -0.1%

Financial Health

Net Cash

$43.18B

Current Ratio 13.40

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipelin...

Sector Healthcare

Industry Biotechnology

Employees 8

IPO Date Dec 28, 2022

Website www.coyatherapeutics.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$12

Upside

+142.42%

Buy (5)

Hold (0)

Sell (0)

Analyst Details ➞